| 1 |
Ghasemi F, Nili-Ahmadabadi A, Omidifar N, Nili-Ahmadabadi M. Protective potential of thymoquinone against cadmium, arsenic, and lead toxicity: A short review with emphasis on oxidative pathways. J Appl Toxicol 2023. [PMID: 36872630 DOI: 10.1002/jat.4459] [Reference Citation Analysis]
|
| 2 |
Ghasemi F, Ghaffari F, Omidifar N, Taheri Azandaryani M, Nili-Ahmadabadi A. Hepatic Response to the Interaction Between Thymoquinone and Iron-Dextran: an In Vitro and In Vivo Study. Biol Trace Elem Res 2023;201:1358-67. [PMID: 35484332 DOI: 10.1007/s12011-022-03249-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Kłos P, Perużyńska M, Baśkiewicz-hałasa M, Skupin-mrugalska P, Majcher M, Sawczuk M, Szostak B, Droździk M, Machaliński B, Chlubek D. Response of Skin-Derived and Metastatic Human Malignant Melanoma Cell Lines to Thymoquinone and Thymoquinone-Loaded Liposomes. Pharmaceutics 2022;14:2309. [DOI: 10.3390/pharmaceutics14112309] [Reference Citation Analysis]
|
| 4 |
Pottoo FH, Ibrahim AM, Alammar A, Alsinan R, Aleid M, Alshehhi A, Alshehri M, Mishra S, Alhajri N. Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases. Pharmaceuticals 2022;15:408. [DOI: 10.3390/ph15040408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Kłos P, Chlubek D. Plant-Derived Terpenoids: A Promising Tool in the Fight against Melanoma. Cancers (Basel) 2022;14:502. [PMID: 35158770 DOI: 10.3390/cancers14030502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Alka, Nisha R, Singh P, Pal RR, Singh N, Mishra N, Saraf SA. Bridging Bio-Nanoscience and Cancer Nanomedicine. Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems 2022. [DOI: 10.1007/978-3-030-83395-4_16] [Reference Citation Analysis]
|
| 7 |
Pandey S, Pathak P, Otuechere CA, Rahman M, Verma A. Effect of Thymoquinone and its Delivery through Using of Nanomedicine in Benign Prostatic Hyperplasia. Hormone Related Cancer Mechanistic and Nanomedicines 2022. [DOI: 10.1007/978-981-19-5558-7_12] [Reference Citation Analysis]
|
| 8 |
Al-Rawashde FA, Johan MF, Taib WRW, Ismail I, Johari SATT, Almajali B, Al-Wajeeh AS, Nazari Vishkaei M, Al-Jamal HAN. Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal SHP-1 and SOCS-3 Hypermethylation: In Vitro and In Silico Evaluation. Pharmaceuticals (Basel) 2021;14:1287. [PMID: 34959687 DOI: 10.3390/ph14121287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Lodovichi J, Landucci E, Pitto L, Gisone I, D'Ambrosio M, Luceri C, Salvatici MC, Bergonzi MC. Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos. Eur J Pharm Sci 2021;169:106090. [PMID: 34864170 DOI: 10.1016/j.ejps.2021.106090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Alhosin M, Abdullah O, Kayali A, Omran Z. A Fast Ubiquitination of UHRF1 Oncogene Is a Unique Feature and a Common Mechanism of Thymoquinone in Cancer Cells. Applied Sciences 2021;11:7633. [DOI: 10.3390/app11167633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
